Lilly Cancer Drug Receives Key Approval – Newsroom – Inside INdiana Business with Gerry Dick

The U.S. Food and Drug Administration has approved a cancer fighting drug from Indianapolis-based Eli Lilly and Co. NYSE: LLY as a maintenance therapy for some lung cancer patients. The clearance allows ALIMTA to be used, following initial treatments, for some advanced non-small cell lung cancers.

via Lilly Cancer Drug Receives Key Approval – Newsroom – Inside INdiana Business with Gerry Dick.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s


%d bloggers like this: